Crinetics Pharmaceuticals, Inc. (CRNX)

40.72 +0.04 (+0.10%) USD  |  NASDAQ  |  Mar 03, 13:22
More

Crinetics Pharmaceuticals Net Change in Capital Expenditures (Quarterly)

Net Change in Capital Expenditures (Quarterly) Chart

View Net Change in Capital Expenditures (Quarterly) for CRNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years

View Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (Quarterly) Benchmarks

View Net Change in Capital Expenditures (Quarterly) Benchmarks
Start Trial
Plus Therapeutics, Inc. Upgrade
Madrigal Pharmaceuticals, Inc. Upgrade
GT Biopharma, Inc. Upgrade
Axsome Therapeutics, Inc. Upgrade
Sutro Biopharma, Inc. Upgrade